INSULIN Act of 2026

The Comptroller General of the United States shall conduct a study, in consultation with patient, clinical, and provider groups and other experts, and not later than 2 years after the date of enactment of this Act, issue a report, on the characteristics of uninsured individuals who use insulin. Such study and report shall, to the extent data is available, include consideration of—

(1) any States or regions in which there is a higher prevalence of such individuals;

(2) any identifiable potential reasons for uninsured status;

(3) demographic characteristics of such individuals, such as race and ethnicity; and

(4) income level of such individuals.